Sebastien Jacquier;Markus Voegtle;Konstanze Hurth;Heinrich Rueeger;Marina Tintelnot-Blomley;Siem Jacob Veenstra;Rainer Machauer
发明人:
Konstanze Hurth,Sebastien Jacquier,Rainer Machauer,Heinrich Rueeger,Marina Tintelnot-Blomley,Siem Jacob Veenstra,Markus Voegtle
申请号：
US14350938
公开号：
US20140256715A1
申请日:
2012.10.11
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention relates to novel oxazine derivatives of formula (I), and pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.
